615 related articles for article (PubMed ID: 25794641)
1. Expression/localization patterns of sirtuins (SIRT1, SIRT2, and SIRT7) during progression of cervical cancer and effects of sirtuin inhibitors on growth of cervical cancer cells.
Singh S; Kumar PU; Thakur S; Kiran S; Sen B; Sharma S; Rao VV; Poongothai AR; Ramakrishna G
Tumour Biol; 2015 Aug; 36(8):6159-71. PubMed ID: 25794641
[TBL] [Abstract][Full Text] [Related]
2. Differential sirtuin expression patterns in amyotrophic lateral sclerosis (ALS) postmortem tissue: neuroprotective or neurotoxic properties of sirtuins in ALS?
Körner S; Böselt S; Thau N; Rath KJ; Dengler R; Petri S
Neurodegener Dis; 2013; 11(3):141-52. PubMed ID: 22796962
[TBL] [Abstract][Full Text] [Related]
3. Expression of sirtuin 1 and 2 is associated with poor prognosis in non-small cell lung cancer patients.
Grbesa I; Pajares MJ; Martínez-Terroba E; Agorreta J; Mikecin AM; Larráyoz M; Idoate MA; Gall-Troselj K; Pio R; Montuenga LM
PLoS One; 2015; 10(4):e0124670. PubMed ID: 25915617
[TBL] [Abstract][Full Text] [Related]
4. Sirtuin inhibitors, EX527 and AGK2, suppress cell migration by inhibiting HSF1 protein stability.
Kim HW; Kim SA; Ahn SG
Oncol Rep; 2016 Jan; 35(1):235-42. PubMed ID: 26530275
[TBL] [Abstract][Full Text] [Related]
5. SIRT1 and SIRT2 inhibition impairs pediatric soft tissue sarcoma growth.
Ma L; Maruwge W; Strambi A; D'Arcy P; Pellegrini P; Kis L; de Milito A; Lain S; Brodin B
Cell Death Dis; 2014 Oct; 5(10):e1483. PubMed ID: 25341037
[TBL] [Abstract][Full Text] [Related]
6. High glucose-induced oxidative stress represses sirtuin deacetylase expression and increases histone acetylation leading to neural tube defects.
Yu J; Wu Y; Yang P
J Neurochem; 2016 May; 137(3):371-83. PubMed ID: 26896748
[TBL] [Abstract][Full Text] [Related]
7. Assessing sirtuin expression in endometrial carcinoma and non-neoplastic endometrium.
Bartosch C; Monteiro-Reis S; Almeida-Rios D; Vieira R; Castro A; Moutinho M; Rodrigues M; Graça I; Lopes JM; Jerónimo C
Oncotarget; 2016 Jan; 7(2):1144-54. PubMed ID: 26701732
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol Induced Premature Senescence Is Associated with DNA Damage Mediated SIRT1 and SIRT2 Down-Regulation.
Kilic Eren M; Kilincli A; Eren Ö
PLoS One; 2015; 10(4):e0124837. PubMed ID: 25924011
[TBL] [Abstract][Full Text] [Related]
9. Gene expression patterns of Sirtuin family members (SIRT1 TO SIRT7): Insights into pathogenesis and prognostic of Myelodysplastic neoplasm.
Goes JVC; Viana MA; Sampaio LR; Cavalcante CBA; Melo MML; de Oliveira RTG; Borges DP; Gonçalves PG; Pinheiro RF; Ribeiro-Junior HL
Gene; 2024 Jul; 915():148428. PubMed ID: 38575099
[TBL] [Abstract][Full Text] [Related]
10. Altered levels of sirtuin genes (SIRT1, SIRT2, SIRT3 and SIRT6) and their target genes in adipose tissue from individual with obesity.
Martínez-Jiménez V; Cortez-Espinosa N; Rodríguez-Varela E; Vega-Cárdenas M; Briones-Espinoza M; Ruíz-Rodríguez VM; López-López N; Briseño-Medina A; Turiján-Espinoza E; Portales-Pérez DP
Diabetes Metab Syndr; 2019; 13(1):582-589. PubMed ID: 30641770
[TBL] [Abstract][Full Text] [Related]
11. Blocking sirtuin 1 and 2 inhibits renal interstitial fibroblast activation and attenuates renal interstitial fibrosis in obstructive nephropathy.
Ponnusamy M; Zhou X; Yan Y; Tang J; Tolbert E; Zhao TC; Gong R; Zhuang S
J Pharmacol Exp Ther; 2014 Aug; 350(2):243-56. PubMed ID: 24833701
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a potent small molecule SIRT1/2 inhibitor with anticancer effects.
Choi G; Lee J; Ji JY; Woo J; Kang NS; Cho SY; Kim HR; Ha JD; Han SY
Int J Oncol; 2013 Oct; 43(4):1205-11. PubMed ID: 23900402
[TBL] [Abstract][Full Text] [Related]
13. Reduced gene expression of sirtuins and active AMPK levels in children and adolescents with obesity and insulin resistance.
Arab Sadeghabadi Z; Nourbakhsh M; Pasalar P; Emamgholipour S; Golestani A; Larijani B; Razzaghy-Azar M
Obes Res Clin Pract; 2018; 12(2):167-173. PubMed ID: 29150224
[TBL] [Abstract][Full Text] [Related]
14. Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect.
Lara E; Mai A; Calvanese V; Altucci L; Lopez-Nieva P; Martinez-Chantar ML; Varela-Rey M; Rotili D; Nebbioso A; Ropero S; Montoya G; Oyarzabal J; Velasco S; Serrano M; Witt M; Villar-Garea A; Imhof A; Mato JM; Esteller M; Fraga MF
Oncogene; 2009 Feb; 28(6):781-91. PubMed ID: 19060927
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, in-vitro evaluation and molecular docking studies of novel indole derivatives as inhibitors of SIRT1 and SIRT2.
Manjula R; Gokhale N; Unni S; Deshmukh P; Reddyrajula R; Srinivas Bharath MM; Dalimba U; Padmanabhan B
Bioorg Chem; 2019 Nov; 92():103281. PubMed ID: 31561106
[TBL] [Abstract][Full Text] [Related]
16. Discovery of thieno[3,2-d]pyrimidine-6-carboxamides as potent inhibitors of SIRT1, SIRT2, and SIRT3.
Disch JS; Evindar G; Chiu CH; Blum CA; Dai H; Jin L; Schuman E; Lind KE; Belyanskaya SL; Deng J; Coppo F; Aquilani L; Graybill TL; Cuozzo JW; Lavu S; Mao C; Vlasuk GP; Perni RB
J Med Chem; 2013 May; 56(9):3666-79. PubMed ID: 23570514
[TBL] [Abstract][Full Text] [Related]
17. SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2.
Peck B; Chen CY; Ho KK; Di Fruscia P; Myatt SS; Coombes RC; Fuchter MJ; Hsiao CD; Lam EW
Mol Cancer Ther; 2010 Apr; 9(4):844-55. PubMed ID: 20371709
[TBL] [Abstract][Full Text] [Related]
18. Tissue-specific deregulation of selected HDACs characterizes ALS progression in mouse models: pharmacological characterization of SIRT1 and SIRT2 pathways.
Valle C; Salvatori I; Gerbino V; Rossi S; Palamiuc L; René F; Carrì MT
Cell Death Dis; 2014 Jun; 5(6):e1296. PubMed ID: 24946089
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of NAD dependent de-acetylases SIRT1 and SIRT2 in B-Cell Chronic Lymphocytic Leukemia (CLL).
Bhalla S; Gordon LI
Cancer Biol Ther; 2016; 17(3):300-9. PubMed ID: 26794150
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of SIRT1 inhibits proliferation and promotes apoptosis of paclitaxel-resistant human cervical cancer cells.
Xia X; Zhou X
Cell Mol Biol (Noisy-le-grand); 2018 May; 64(6):36-41. PubMed ID: 29808798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
